Reversal of cognitive impairment in an elderly parkinsonian patient by transcranial application of picotesla electromagnetic fields

International Journal of Neuroscience

Volumn 91, Issue 1-2, 1997, Pages 57-68

  Sandyk, Reuven ^a,b  

^a TOURO COLLEGE   (United States)

^b NONE   (United States)

Author keywords

Dementia; Electromagnetic fields; Left hemispheric dysfunction; Parkinson's disease; Tremor

Indexed keywords

EID: 0031239339     PISSN: 00207454     EISSN: None     Source Type: Journal    
DOI: 10.3109/00207459708986365     Document Type: Article

References (110)

1. Ajuriaguerra, J , Muller, M. & Tissot, R. (1960). A propos de quelques problemes poses par l'apraxie dans les demences. Encephale, 49, 275-401.
2. Alvord, E. C. (1971). The pathology of Parkinsonism: Part II. An interpretation with special reference to other changes in the aging brain. In: F H. McDowell & C. H. Markham (eds.), Recent advances in parkinson's disease. (Davis, Philadelphia.)
3. Anden, N. E., Carlsson, A., Kerstell, J., Magnusson, T., Olsson, R., Roos, B E., Steen, B., Steg, G., Svanborg, A., Thieme, G. & Werdinius, B. (1970). Oral L-dopa treatment of parkinsonism. Acta Medica Scandinavica, 187, 247-256.
4. Arrigoni, G. & De Renzi, E (1964). Constructional apraxia and hemispheric locus of lesion Cortex, 1, 170-197.
5. Azmitia, E. C. & Gannon, P. J. (1986). Primate serotonergic system: a review of human and animal studies and a report on Macaca fascicularis. Advances in Neurology, 43, 407-468.
6. Battersby, W. S., Bender, M. B., Pollack, M. & Kahn, R. L. (1956). Unilateral "spatial agnosia" in patients with cortical lesions. Brain, 79, 68-93.
7. Baumgarten, H. G. & Lachenmayer, L. (1985). Anatomical features and physiological properties of central serotonin neurons. Pharmucopsychiatrie, 18, 180-187.
8. Beardsley, J. V. & Puletti, F. (1971). Personality (MMPI) and cognitive (WAIS) changes after levodopa treatment. Archives of Neurology, 25, 145-150.
9. Bentin, S., Silverberg, R. & Gordon, H. W. (1981). Asymmetrical cognitive deterioration in demented and parkinsonian patients. Cortex, 17, 533-544.
10. Benton, A. L. & Fogel, M. L. (1962). Three-dimensional constructional praxis. Archives of Neurology, 7, 347-354.
11. Berger, B. (1977). Histochemical identification and localization of dopaminergic axons in rat and human cerebral cortex. Advances in Biochemical Psychopharmacology, 16, 13-20.
12. Boller, F., Mizutani, T., Roessmann, U. & Gambetti, P. (1980). Parkinson disease, dementia, and Alzheimer's disease: clinicopathologic correlations. Annals of Neurology, 7, 329-335.
13. Boller, F., Passafiume, D., Keefe, N. C., Rogers, K., Morrow, L. & Kim, Y. (1984). Visuospatial impairment in Parkinson's disease. Role of perceptual and motor factors. Archives of Neurology, 41, 485-490.
14. Bowen, F. P , Hoehn, M. M. & Yahr, M. D. (1972). Parkinsonism: alterations in spatial orientation as determined by a route-walking test. Neuropsychoogia, 10, 355-361.
15. Brozoski, T. J., Brown, R. M., Rosvold, H. E. & Goldman, P. S. (1979). Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science, 205, 929-932.
16. Candy, J. M., Perry, R. H. & Perry, E. K. (1983). Pathological changes in the nucleus basalis of Meynert in Alzheimer's and Parkinson's diseases. Journal of Neurological Sciences, 54, 277-289.
17. Comings, D. E. (1990). Tourette syndrome and human behavior (pp. 341-361). (Hope Press, Duarte, CA.)
18. De Renzi, E. & Faglioni, P. (1967). The relationship between visuospatial impairment and constructional apraxia. Cortex, 3, 327-342.
19. DeRenzi, E., Faglioni, P. & Scotti, G. (1970). Hemispheric contribution to exploration of space through the visual and tactile modality. Cortex, 6, 191-203.
20. Descarries, L., Beaudet, A. & Watkins, K. C. (1975). Serotonin nerve terminal in adult rat neocortex. Brain Research, 100, 563-588.
21. Direnfeld, L. K., Albert, L. M., Lolicer, L., Langlais, P. J., Marquis, I. & Kaplan, E. (1984). Parkinson's disease: the possible relationship of laterality to dementia and neurochemical findings. Archives of Neurology, 41, 935-941.
22. Forno, L. S. & Norville, R. L. (1981). Synaptic morphology in the human locus coeruleus. Acta Neuropathologica, 53, 7-14
23. Forno, L. S., Barbour, P. J. & Norville, R. L. (1978). Presenile dementia with Lewy bodies and neurofibrillay tangles. Archives of Neurology, 35, 818-822.
24. Freedman, M., Leach, L., Kaplan, E., Winocur, G., Shulman, K. I. & Delis, D. C. (1994) Clock drawing: a neuropsychological analysis, pp. 6-8. (Oxford University Press, New York.)
25. Gainotti, G. & Tiacci, C. (1970). Patterns of drawing disability in right and left hemispheric patients. Neuropsychologia, 8, 379-384.
26. Gibb, W. R. G. (1989). Dementia and Parkinson's disease. British Journal of Psychiatry, 154, 596-614.
27. Goldenberg, G., Podreka, I., Muller, C. & Deecke, L. (1989). The relationship between cognitive deficits and frontal lobe functions in patients with Parkinson's disease: An emission computerized tomography study. Behavoral Neurology, 2, 79-87.
28. Granerus, A. K. (1978). Factors influencing the occurrence of "on-off" symptoms during long-term treatment with L-dopa. Acta Medica Scandinavica, 203, 75-85.
29. Hakim, A. M. & Mathieson, G. (1979). Dementia in Parkinson's disease: a neuropathologic study. Neurology, 29, 1209-1214.
30. Halgin, R., Riklan, M. & Misiak, H. (1977). Levodopa, parkinsonism and recent memory. Journal of Nervous and Mental Disease, 164, 268-272.
31. Heilman, K. M., Watson, R. T. & Valenstein, E. (1985). Neglect and related disorders. In: K. M. Heilman & E. Valenstein (Eds.), Clinical neuropsychology, pp. 243-293, (Oxford University Press, Oxford.)
32. Henderson, V. W., Mack, W. & Williams, B. W. (1989). Spatial disorientation in Alzheimer's disease. Archives of Neurology, 46, 391-394.
33. Hoehn, M. M. & Yahr, M. D. (1967) Parkinsonism: onset, progression and mortality. Neurology, 17, 427-442.
34. Hornykiewicz, O. (1982). Brain neurotransmitter changes in Parkinson's disease In: C. D. Marsden & S. Fahn (eds.), Movement disorders, pp. 41-58. (Butterworths, London.)
35. Hovestadt, A., De Jong, G. J. & Meerwaldt, J. D. (1988). Spatial disorientation in Parkinson's disease no effect of levodopa substitution therapy. Neurology, 38, 1802-1803.
36. Hughes, A. J., Daniel, S. E., Blankson, S. & Lees. A. J. (1993). A clinicopathologic study of 100 cases of Parkinson's disease. Archives of Neurology, 50, 140-148.
37. Javoy-Agid, F. & Agid, Y. (1980). Is the mesocortical dopaminergic system involved in Parkinson's disease? Neurology, 30, 1326-1330.
38. Kirk, A. & Kertesz, A. (1989). Hemispheric contributions to drawing. Neuropsvchologia, 27, 881-886
39. Kirk, A. & Kertesz, A. (1991). On drawing impairment in Alzheimer's disease. Archives of Neurology, 48, 73-77.
40. Klawans, H. L. (1988). Psychiatric side effects during the treatment of Parkinson's disease. Journal of Neural Transmission, 27 (suppl), 117-122.
41. Kleist, K (1922). Kriegsverletzungen des Gehirns. In: Schjerning, O. (ed.), Handbuch der Artzlichen Erfahrungen im Weltkrieg. 1914-1918 (Barth, Leipzig, Germany.)
42. Korczyn, A. D., Inzelberg, R., Treves, T., Neufeld, M., Reider, I & Rabey, P. M. (1986). Dementia of Parkinson's disease. In: M. D. Yahr & K. J. Bergmann (eds.), Advances in Neurology, pp. 399-403. (Raven Press, New York).
43. Kuhl, D. E., Metter, E. J. & Benson, D. F. (1985). Similarities of cerebral glucose metabolism in Alzheimer's and parkinsonian dementia. Journal of Cerebral Blood Flow and Metabolism, 5 (suppl), S169.
44. Larrabee, G. J. & Kane, R. L. (1983). Differential drawing size associated with unilateral brain damage. Neuropsychologia, 21, 173-177.
45. Lebrun, Y. & Hoops, R. (1974). Intelligence and aphasia. (Swets & Zeitlinger, B. V., Amsterdam.)
46. Leverenz, J. & Sumi, S. M. (1986). Parkinson's disease in patients with Alzheimer's disease. Archives of Neurology, 43, 662-664.
47. Levin, B. E., Llabre, M. M., Reisman, S., Weiner, W J., Sanehez-Ramos, J , Singer, C. & Brown, M. C. (1991). Visuospatial impairment in Parkinson's disease. Neurology, 41, 365-369.
48. Lezak, M D. (1995). Neuropsychological assessment, pp. 581-587, Third Edition. (Oxford University Press, New York.)
49. Lhermitte, J. & Trelles, J. O. (1933). Sur l'apraxie pure constructive. Encephale, 28, 413-444.
50. Lindvall, O., Bjorklund, A., Moore, R. Y. & Stenevi, U. (1974). Mesencephalic dopamine neurons projecting to neocortex. Brain Research, 81, 325-331.
51. Loranger, A W., Goodell, H., McDowell, F. H., Lee, J. E. & Sweet, R. D. (1972). Intellectual impairment in Parkinson's disease. Brain, 95, 405-412.
52. Mayer-Gross, W. (1935). Some observations on apraxia. Proceedings of the Royal Society of Medicine, 28, 1203-1212.
53. Mayeux, R. (1987). Mental state. In: W. C. Koller (ed.), Handbook of parkinson's disease, pp. 127-144. (Marcel Dekker, New York).
54. Mayeux, R., Stern, Y. & Rosen, J (1980). Visuospatial function in Parkinson's disease. Neurology, 30, 392.
55. Mayeux, R., Stern, Y., Rosen, J. & Leventhal, J. (1981). Depression, intellectual impairment and Parkinson's disease. Neurology, 31, 645-650.
56. Mayeux, R., Sterm, Y., Sano, M. Cote, L. & Williams, J. B. W. ( 1987). Clinical and biochemical correlates of bradyphrenia in Parkinson's disease. Neurology, 37, 1130- 1134.
57. Mesulam, M. M. (1981). A cortical network for directed attention and unilateral neglect. Annals of Neurology, 10, 304-325.
58. McCance-Katz, E. F., Marek, K. L. & Price, L H. (1992). Serotonergic dysfunction in depression associated with Parkinson's disease. Neurology, 42, 1813-1814.
59. McFie, J. & Zangwill, O. L. (1960). Visual constructive disabilities associated with lesion of the left cerebral hemisphere. Brain, 83, 243-260.
60. Mohr, E., Juncos, J., Cox, C., Litvan, I., Fedio, P. & Chase, T. N. (1990). Selective deficits in cognition and memory in high-functioning Parkinsonian patients. Journal of Neurology, Neurosurgery and Psychiatry, 53, 603-606.
61. Mortimer, J. A., Pirozzolo, F. J., Hansch, E. C. & Webster, D. D. (1982). Relationship of motor symptoms to intellectual deficits in Parkinson's disease Neurology, 32, 133-137.
62. Nagasaki, H., Kosaka, K. & Nakamura, R. (1981). Distribution of rhythm formation in patients with hemispheric lesion. Tohoku Journal of Experimental Medicine, 135, 231-236.
63. Nausieda, P. A., Weiner, W. J., Kaplan, L. R., Weber, S. & Klawans, H. L. (1982). Sleep disruption in the course of chronic levodopa therapy: An early feature of the levodopa psychosis. Clinical Neuropharmacolog, 5, 183-194
64. Nutt, J. G., Hammerstand, J. P. & Gancher, S T (1992) Parkinson's disease-100 maxims, pp. 112-113. (Edward Arnold, London.)
65. Ogden, J. A., Growdon, J. H. & Corkin, S. (1990). Deficits on visuospatial tests involving forward planning in high-functioning parkinsonians. Neuropsychiatry, Neuropsychology and Behavioral Neurology, 3, 125-139.
66. Oxbury, J. M., Campbell, D. C. & Oxbury, S. M. (1974). Unilateral spatial neglect and impairments of spatial analysis and visual perception. Brain, 97, 551-564.
67. Paterson, A. & Zangwill, O. L. (1944). Disorders of visual space perception associated with lesions of the right cerebral hemisphere. Brain, 67, 331-358.
68. Pearce, J. M. S., Flowers, K., Pearce, J. & Pratt, A. E. (1981). Clinical, psychometric and CAT scan correlations in Parkinson's disease. In: Clifford Rose, F. & Capildeo, R. (Eds.), Research progress in Parkinson's disease, pp. 43-52. (Pitman Medical, Kent.)
69. Piccirilli, M., D'Alessandro, P., Finali, G., Piccinin, G. L. & Agostini, L (1989). Frontal lobe dysfunction in Parkinson's disease, prognostic value for dementia? European Neurology, 29, 71-76.
70. Pillon, B . Dubois, B., Bonnet, A. M., Esteguy, M., Guimaraes, J., Vigouret, J. M., L'hermitte, F. & Agid, Y. (1989). Cognitive slowing in Parkinson's disease fails to respond to levodopa treatment: the 15-objects test. Neurology, 39, 762-768.
71. Pirozzolo, F. J., Hansch, E. C. & Mortimer, J. A. (1982). Dementia in Parkinson's disease: A neuropsychological analysis. Brain and Cognition, 1, 71-83.
72. Reading, P. J. (1991). Frontal lobe dysfunction in schizophrenia and Parkinson's disease- a meeting point for neurology, psychology and psychiatry: discussion paper. Journal of the Royal Society of Medicine, 84, 349-353.
73. Riklan, M , Zahn, T. P. & Diller, L. (1962). Human figure drawings before and after chemosurgery of the basal ganglia in Parkinsonism. Journal of Nervous and Mental Disease, 135, 500-506.
74. Rinne, J. O., Rummukainen, J., Paljarvi, L & Rinne, U. K. (1989). Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra. Annals of Neurology, 26, 47-50.
75. Rosenblum, W. I. & Ghatak, N. R. (1979). Lewy bodies in the presence of Alzheimer's disease. Archives of Neurology, 36, 170-171.
76. Sacks, O., Kohl, M S., Messeloff, C. R. & Schwartz, W. F. (1972). Effects of levodopa in parkinsonian patients with dementia. Neurology, 22, 516-519.
77. Sandyk, R. (1992). Magnetic fields in the therapy of parkinsonism. International Journal of Neuroscience, 66, 209-235.
78. Sandyk, R. (1993). The effects of picotesla range magnetic fields on perceptual organization and visual memory in parkinsonism. International Journal of Neuroscience, 73, 207-219.
79. Sandyk, R. (1994 a). Reversal of a visuoconstructional deficit in Parkinson's disease by application of external magnetic fields: A report of five cases. International Journal of Neuroscience, 75, 213-228.
80. Sandyk, R. (1994 b). A drug naive Parkinsonian patient successfully treated with electromagnetic fields. International Journal of Neuroscience, 79, 99-110.
81. Sandyk, R. (1994 c). Improvement in word fluency performance in Parkinson's disease by administration of electromagnetic fields. International Journal of Neuroscience, 77, 23-46.
82. Sandyk, R. (1995 a). Weak electromagnetic fields reverse visuospatial hemi-inattention in Parkinson's disease. International Journal of Neuroscience, 81, 47-65
83. Sandyk, R. (1995 b). Reversal of a visuospatial deficit on the clock drawing test in Parkinson's disease by treatment with weak electromagnetic fields. International Journal of Neuroscience, 82, 255-268.
84. Sandyk, R. (1995 c). Improvement in short-term visual memory by weak electromagnetic fields in Parkinson's disease. International Journal of Neuroscience, 81, 67-82.
85. Sandyk, R. (1995 d ). Improvement of body image perception in Parkinson's disease by treatment with weak electromagnetic fields. International Journal of Neuroscience, 82, 269-283,
86. Sandyk, R. (1996 a). Electromagnetic fields improve visuospatial performance and reverse agraphia in a Parkinsonian patient. International Journal of Neuroscience, 87, 209-217.
87. Sandyk, R. (1996 b). The long term impact of treatment with electromagnetic fields on visual memory in Parkinson's disease. International Journal of Neuroscience, 86, 257-262.
88. Sandyk, R. & Derpapas, K. (1993 a). Further observations on the unique efficacy of picotesla magnetic fields in Parkinson's disease. International Journal of Neuroscience, 69, 167-183.
89. Sandyk, R. & Derpapas, K. (1993 b) The effects of external picotesla range magnetic fields on the EEG in Parkinson's disease. International Journal of Neuroscience, 70, 85-96.
90. Sandyk, R. &. Fisher, H (1988). Serotonin in involuntary movement disorders. International Journal of Neuroscience, 42, 185-205.
91. Sandyk, R. & Iacono, R. P. (1993 a). Rapid improvement of visuoperceptive functions by picotesla range magnetic fields in Parkinson's disease, International Journal of Neuroscience, 70, 233-254.
92. Sandyk, R. & Iacono, R. P. (1993 b). Reversal of visual neglect in Parkinson's disease by treatment with picotesla range magnetic fields. International Journal of Neuroscience, 73, 93-107.
93. Sano, M., Stern, Y., Williams, J. & Cote, L., Rosenstein, R. & Mayeux, R. (1989). Coexisting dementia and depression in Parkinson's disease. Archives of Neurology, 46, 1284-1286
94. Scatton, B., Rouquier, L., Javoy-Agid, F. & Agid, Y. (1982). Dopamine deficiency in the cerebral cortex in Parkinson disease. Neurology, 32, 1039-1040.
95. Simon, H., Scatton, B. & LeMoal, M. (1980). Dopaminergic A10 neurones are involved in cognitive functions. Nature, 286, 150-151.
96. Sjogren, T., Sjogren, H. & Lindgren. A. G. H. (1952). Morbus Alzheimer and morbus Pick. Acta Psychiatrica Neurologica Scandinavica, 82 (suppl), 1-152.
97. Sweet, R. D., McDowell, F. H. & Feigenson, J. S. (1976). Mental symptoms in Parkinson's disease during chronic treatment with levodopa. Neurology, 26, 305-310.
98. Starkstein, S. E., Preziosi, T. J., Berthier, M. L., Bolduc, P. L., Mayberg, H. S. & Robinson, R. G. (1989). Depression and cognitive impairment in Parkinson's disease. Brain, 112, 1141-1153.
99. Stern, Y., Richards, M., Sano, M. & Mayeux, R. (1993). Comparison of cognitive changes in patients with Alzheimer's and Parkinson's disease. Archives of Neurology, 50, 1040-1045.
100. Sulkava, R., Haltia, M. & Paetau, A. (1983). Accuracy of clinical diagnosis in primary degenerative dementia: correlation with neuropathological findings. Journal of Neurology, Neurosurgery and Psychiatry, 46, 9-13.
101. Taylor, E. M. (1959). The appraisal of children with cerebral deficits. (Mass: Harvard University Press, Cambridge.)
102. Tohgi, H , Abe, T., Takahashi, S., Takahashi, J. & Hamato, H. (1993). Alterations in the concentration of serotonergic and dopaminergic substances in the cerebrospinal fluid of patients with Parkinson's disease and their changes after L-dopa administration. Neuroscience Letters, 159, 135-138.
103. Torack, R. M. & Morris, J. C. ( 1988). The association of ventral tegmental area histopathology with adult dementia. Archives of Neurology, 45, 497-501.
104. Uhl, G. R., Hedreen, J C. & Price, D. L. (1985). Parkinson's disease: loss of neurons from the ventral tegmental area contralateral to therapeutic surgical lesions. Neurology, 35, 1215-1218.
105. Villardita, C., Smirni, P. & Le Pira, F. (1982). Mental deterioration, visuoperceptive disabilities and constructional apraxia in Parkinson's disease. Acta Neurologica Scandinavica, 66, 112-120.
106. Villardita, C., Smimi, P. & Zappala, G. (1983). Visual neglect in Parkinson's disease. Archives of Neurology, 40, 737-739.
107. Whitehouse, P. J., Hedreen, J. C., While, C. L. & Price, D. L. (1983). Basal forebrain neurons in the dementia of Parkinson disease. Annals of Neurology, 13, 243-248.
108. Wolf-Klein, G. P., Silverstone, F. A., Levy, A. P. & Brod, M. S. (1989). Screening for Alzheimer's disease by clock drawing. Journal of the American Geriatrics Society, 37, 730-734.
109. Yagishita, S., Itoh, Y., Amano, N. & Nakano, T. (1979). Atypical senile dementia with widespread Lewy type inclusion body in the cerebral cortex. Acta Neuropathologica, 49, 187-191.
110. Yanagisawa, N., Fujimoto, S. & Ueno, B. (1985). Neurophysiological aspects of Parkinson's disease. In: Y. Kuroiwa & Y. Toyokura (eds.), Current problems in treatment of parkinson's disease, pp. 13-22 (DMW. Tokyo, Japan.)